Brief: Eledon Pharmaceuticals FY Operating Expenses USD 70.577 Million
March 20 (Reuters) - Eledon Pharmaceuticals Inc ELDN.O: ELEDON PHARMACEUTICALS FY OPERATING EXPENSES USD 70.577 MILLION ELEDON PHARMACEUTICALS FY NET INCOME USD -36.184 MILLION ELEDON PHARMACEUTICALS FY BASIC EPS USD -0.75 Source text: ID:nGNX1QNDZG Further company coverage: ELDN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial